Navigation Links
First Controlled Large-Scale Intervention Angiotensin Receptor,Blocker (ARB) Trial in a Japanese Population, JIKEI HEART Study,Demonstrates Significant Reduction in Blood Pressure and Protection,of Organs with Valsartan

rgans."

In the JIKEI HEART Study, treatment was initiated in a population with an average starting blood pressure of 139/81 mmHg -- already below the national guideline level for hypertension without comorbidities. The blood pressure target was set at 130/80 mmHg. The non-ARB group achieved 132/78 mmHg and the valsartan group achieved 131/77 mmHg. The valsartan group also showed a significant drop in composite cardiovascular events: the primary endpoint cardiovascular events were compared between the groups with the valsartan- added group exhibiting significant relative reductions, including a 65% reduction in angina pectoris, 46% in heart failure and 81% in aortic dissection. These benefits cannot be entirely explained by differences in blood pressure control.

"We are very proud that the University has led yet another landmark, large-scale clinical study. We are equally proud that the important findings of the JIKEI HEART Study were published in the prestigious general medical journal The Lancet, which also marks the 120-year anniversary of our first large-scale trial on beriberi published in the same medical journal," said Satoshi Kurihara, President, Jikei University School of Medicine. "In accordance with our mission of patient-centered medical care, the JIKEI HEART Study provides invaluable clinical insight into current and future treatments for the benefit of patients. We are grateful to the patients for their cooperation, and the physicians who ensured a high level of accuracy with a patient follow-up rate of 99%. The design of the physician-lead study provides a direction for future clinical investigations while attaining a high level of international commendation."

About the large-scale clinical JIKEI HEART Study

The JIKEI HEART Study was a multi-center comparative study with a prospective randomized open-label blinded endpoint (PROBE) design conducted by physicians. The study involved 3,081 Japanese patients aged 20 to 79 with h
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
3. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
4. Ablynx Announces Interim Results of First Nanobody Phase I Study of ALX-0081 (ANTI-VWF)
5. Advanced Life Sciences Announces Supplemental Efficacy Data from First Pivotal Phase 3 Pneumonia Clinical Trial
6. Advanced Life Sciences to Host Conference Call to Discuss Data From Cethromycins First of Two Phase 3 Pneumonia Trials
7. First Phase II Short-Term Study on Dapagliflozin Shows Results on Safety, Tolerability and Glycemic Markers in Subjects With Type 2 Diabetes
8. Advanced Cell Technology Develops First Human Embryonic Stem Cell Line without Destroying an Embryo
9. First Demonstration of nanoImmunology: a Nanomaterials-based Therapeutic Approach to Treat Allergy
10. First single breast cancer study to show significant survival benefit for women switching from tamoxifen to Arimidex
11. Mymetics HIV Vaccine Demonstrates First-Ever Production of Neutralizing IgA Antibodies in Non-Human Primate Model
Post Your Comments:
(Date:9/15/2014)... , Sept. 15, 2014  Catalist-listed QT Vascular ... Group"), a developer and manufacturer of minimally invasive medical ... to announce that the Group has enrolled the first ... Germany . Multiple patients have already been enrolled ... at Auckland City Hospital, in Auckland, New ...
(Date:9/15/2014)... PDL BioPharma, Inc. (PDL) (NASDAQ: ... September 12, 2014, regular quarterly dividend payment of $0.15 per ... of September 5, 2014, the record date. ... portfolio of patents and royalty assets, consisting primarily of ... agreements with various biotechnology and pharmaceutical companies. PDL pioneered ...
(Date:9/15/2014)... Sept. 15, 2014 Research and Markets ... Drug Transfer Systems to 2020" report to their ... hazardous to humans has been receiving increasing amounts of ... substances become more clearly understood. For caregivers and their ... of attempts to mitigate exposure to cytotoxic drugs is ...
Breaking Medicine Technology:First European Patients Enrolled in QT Vascular's ENDURE Trial 2First European Patients Enrolled in QT Vascular's ENDURE Trial 3First European Patients Enrolled in QT Vascular's ENDURE Trial 4First European Patients Enrolled in QT Vascular's ENDURE Trial 5PDL BioPharma Completes Regular Quarterly Dividend Payment 2Closed Drug Transfer Systems to 2020 2Closed Drug Transfer Systems to 2020 3
... Germany, Sept. 20, 2011 Weight and height, their ... for medical measuring and weighing. Now the company is ... integrating modern medical practices and hospital equipment. The new ... of precise data capture, transmission and interpretation of weight, ...
... – Ingenuity® Systems, a leading provider of ... researchers, today announced the addition of new ... miRecords , plus thousands of additional miRNA-mRNA ... The newly added content supplements existing experimentally ...
Cached Medicine Technology:seca 360 wireless - The New Era of Measuring and Weighing 2Ingenuity Announces New Additional MicroRNA Content to Complement First-of-its-Kind MicroRNA Filtering Capability in IPA 2
(Date:9/15/2014)... DALLAS, TX September 12, 2014 - An estimated ... disorder (PTSD) at some point during their lifetime. Brought ... PTSD is the result of altered chemistry and physiology ... a normal brain versus one altered by PTSD is ... from the Center for BrainHealth at The University of ...
(Date:9/15/2014)... 2014 The White House has recently ... offenders in jail and prison and toward helping them ... as a positive change. , The nation is currently ... abuse. According to an article from The Washington ... a shift away from using the criminal justice system ...
(Date:9/15/2014)... 2014 This year, Avenidas Village ... 2007. To mark the special occasion, Avenidas Village would ... village and helping it to get started seven years ... fun community for seniors. Members of Avenidas Village maintain ... in their own homes. They are able to have ...
(Date:9/15/2014)... Maureen Salamon HealthDay ... -- Pediatricians prescribe antibiotics about twice as often as ... infections, a new study indicates. More than 11 ... teens may be unnecessary, according to researchers from University ... use not only fails to eradicate children,s viral illnesses, ...
(Date:9/15/2014)... By Amy Norton ... -- A relatively small number of medications are responsible for ... ingestion, a U.S. government study finds. Each year between ... years were hospitalized after getting a hold of family members, ... Prevention. "Three-quarters of those children were just 1 ...
Breaking Medicine News(10 mins):Health News:EEG study findings reveal how fear is processed in the brain 2Health News:White House Shifts Policy on Drugs 2Health News:Avenidas Village Celebrates Anniversary 2Health News:Kids Prescribed Antibiotics Twice as Often as Needed, Study Finds 2Health News:Kids Prescribed Antibiotics Twice as Often as Needed, Study Finds 3Health News:Small Number of Drugs Behind Kids' Accidental Poisonings: CDC 2Health News:Small Number of Drugs Behind Kids' Accidental Poisonings: CDC 3
... and Highlights Potential Factors that Affect Health Outcomes, in ... N.J., Jan. 14 Results from the LATINO study, ... the hepatitis C virus (HCV), were published today in ... This Roche study demonstrated that HCV can be successfully ...
... considerable reduction in infection rates, , , WEDNESDAY, Jan. 14 ... life-threatening infection, have declined substantially since a new vaccine ... The declines have been seen not only in children ... herd immunity effect, the researchers noted. To assess the ...
... 14 Home Care Assistance has,partnered with a ... consistently high rankings in sponsored and organic searches ... that delivers thousands of,leads critical to franchisee business ... commitment to provide solutions that offer immediate,business results ...
... of Inauguration Day, Berry,Chill is offering free Berry Obama ... , The Berry Obama is ... with blueberries, blue candy-covered almonds, and blue,sprinkles to reflect ... the special combination will be topped with fresh pomegranate,coconut ...
... 14 A surge of arctic air forecast to ... chills that could lead to serious health problems, the ... to range from the single digits to minus 10 ... to 30 below zero. "Taking preventive action can help ...
... Benzoyl Peroxide Wash to Utilize MICROSPONGE(R) Delivery SystemCARLSBAD, ... the launch of NeoBenz Micro Wash, ... with the MICROSPONGE (R) delivery system, for ... NeoBenz Micro Wash contains 7% benzoyl ...
Cached Medicine News:Health News:PEGASYS(R) Proven Effective as Hepatitis C Treatment for Latino Patients, According to Article in The New England Journal of Medicine 2Health News:PEGASYS(R) Proven Effective as Hepatitis C Treatment for Latino Patients, According to Article in The New England Journal of Medicine 3Health News:PEGASYS(R) Proven Effective as Hepatitis C Treatment for Latino Patients, According to Article in The New England Journal of Medicine 4Health News:PEGASYS(R) Proven Effective as Hepatitis C Treatment for Latino Patients, According to Article in The New England Journal of Medicine 5Health News:PEGASYS(R) Proven Effective as Hepatitis C Treatment for Latino Patients, According to Article in The New England Journal of Medicine 6Health News:PEGASYS(R) Proven Effective as Hepatitis C Treatment for Latino Patients, According to Article in The New England Journal of Medicine 7Health News:PEGASYS(R) Proven Effective as Hepatitis C Treatment for Latino Patients, According to Article in The New England Journal of Medicine 8Health News:PEGASYS(R) Proven Effective as Hepatitis C Treatment for Latino Patients, According to Article in The New England Journal of Medicine 9Health News:Meningitis Vaccine Seems to Work Like a Charm 2Health News:Meningitis Vaccine Seems to Work Like a Charm 3Health News:Home Care Franchise Forms Strategic Partnership with Google(TM) 2Health News:Inauguration Day Deal: Get a Free Berry Obama Chilled Yogurt at Berry Chill 2Health News:Department of Health Urges Pennsylvanians to Prepare For Dangerously Cold Weather 2Health News:SkinMedica(R) Launches NeoBenz(R) Micro Wash for Acne 2Health News:SkinMedica(R) Launches NeoBenz(R) Micro Wash for Acne 3
... unique system uses prolene as thread-guide reducing ... The hollow Ritleng Probe is inserted into ... thread-guide is fed through it. The probe ... to pull the silicone tubing in place. ...
... For canalicular laceration or imperforate ... and Stainless Steel Probe. Box ... securely swaged into malleable stainless ... by punctum plug: no knots, ...
For Canalicular Stenosis. Non-traumatic tip. Silicone tubing swaged into probe. Note: Tubing securely swaged into malleable stainless steel probes. Medical grade silicone. Box of 3, sterile....
Recommended to insert plug portion of all monocanalicular intubation systems into punctum....
Medicine Products: